Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Withdrawn NCT05309902

A Study of Soticlestat in Healthy Adults To Evaluate the Effect on QTc Interval

Conditions: Healthy Volunteers

Sex: All
Ages: 18 Years – 55 Years
Healthy volunteers: Yes
Phase: PHASE1
Sponsor: Takeda

Summary

The main aim is to see if soticlestat has any effect in the heart rate. Participants will receive 4 doses of soticlestat in tablets and will complete some assessment which include to record activity of the heart and collection of blood samples. Then, the clinic will contact the participants 14 days after their final dose of soticlestat to check if they have any health problems.

Eligibility Criteria

Inclusion Criteria: 1. Male participants agree to comply with any applicable contraceptive requirements of the protocol. 2. Body mass index (BMI) greater than or equal to (\>=)18.0 and \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05309902). StuddyBuddy aggregates publicly available trial information.